Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 13 2022

Full Issue

US Shareholder Case Over AstraZeneca Covid Shot Research Dismissed

The lawsuit had claimed the drugmaker had concealed problems during development of its covid vaccine. Separately, in Europe, regulators have cleared Pfizer's updated booster shots targeting later covid variants, amid news 17 million Europeans got long covid early in the pandemic.

Reuters: AstraZeneca Beats U.S. Shareholder Lawsuit Over COVID Vaccine Disclosures 

AstraZeneca Plc (AZN.L) on Monday won the dismissal of a U.S. shareholder lawsuit claiming that it concealed problems in developing its COVID-19 vaccine, making it unlikely the treatment would win regulatory approval in the United States. (Stempel, 9/12)

More on the global fight against covid —

AP: EU Regulator Clears Pfizer-BioNTech's Tweaked COVID Booster 

The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter. (9/12)

Bloomberg: Afrigen Biologics Covid Vaccine Candidate Human Trials To Start By May

Afrigen Biologics & Vaccines plans to start human trials of its Covid-19 vaccine candidate by May, part of a World Health Organization-backed plan to develop locally-made inoculations in the developing world. (Sguazzin, 9/13)

The Washington Post: Stuck In China's Covid Lockdown, People Plead For Food, Medical Care 

Frantic appeals for food and medical care are spreading across China in a grim deja vu, as tens of millions of people are put under weeks-long coronavirus lockdowns ahead of a key meeting of the ruling Communist Party. While much of the world is moving past the pandemic, China remains stuck, with leader Xi Jinping continuing orders to maintain “zero covid.” These lockdowns are keeping localized outbreaks from spreading but are taking an enormous economic and psychological toll on the population. (Dou and Chiang, 9/12)

In other health news from Ukraine and Syria —

Houston Chronicle: Houston Doctors Helping Ukraine Diagnose, Treat Brain Injuries

Dr. Kenneth Podell, a neuropsychologist who is the director of the Houston Methodist Concussion Center, and Dr. Mary Rose Newsome, a cognitive neuroscientist and associate professor at Baylor College of Medicine, are among a half-dozen American doctors who are providing medical and financial aid to their counterparts in Ukraine. (MacDonald, 9/12)

Reuters: Cholera Outbreak In Syria Poses Serious Threat 

A cholera outbreak in several regions of Syria presents "a serious threat to people in Syria and the region", the United Nations representative in the country said, calling for an urgent response to contain its spread. (9/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF